Pterygium:

Clinical Benefits:

• Simplifies the procedure
• Low recurrence rate
• Improved patient results
• Reserves conjunctival tissue for other use

Supporting Literature:

• Ma DH, See LC, Hwang YS, Wang SF. Comparison of amniotic membrane combined with intraoperative mitomycin C to prevent recurrence after excision of recurrent pterygia. Cornea 2005 Mar;24(2):141-50.
• Shimazak J, Kosaka K, Shimmura S, Tsubota K. Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium. Ophthalmology 2003 Jan;110(1):119–24.

For more information visit http://osref.org/pterygium-pinguecula.aspx